Status: current, Defined. Date: 31-May 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4566441000168114 | buprenorphine 160 mg / 0.45 mL modified release injection, 1 x 0.45 mL syringe (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4566451000168111 | buprenorphine 160 mg/0.45 mL modified release injection, 0.45 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| buprenorphine 160 mg/0.45 mL modified release injection, 0.45 mL syringe | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| buprenorphine 160 mg/0.45 mL modified release injection, 0.45 mL syringe | has MPUU | buprenorphine 160 mg/0.45 mL modified release injection, syringe | true | Inferred relationship | Some | 349894627 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Buvidal Monthly 160 mg/0.45 mL modified release injection, 0.45 mL syringe | Is a | True | buprenorphine 160 mg/0.45 mL modified release injection, 0.45 mL syringe | Inferred relationship | Some |
Reference Sets
Schedule 8 medications reference set
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR